All Stories

  1. β-1,3-glucan-lacking Aspergillus fumigatus mediates an efficient antifungal immune response by activating complement and dendritic cells

    Article • Virulence, October 2018, Taylor & Francis

    Dr Johannes Wagener, Lukas Huber, Professor Hubertus Haas, Professor Doris Wilflingseder, Axel Brakhage

  2. Oxidative Stress Response Tips the Balance in Aspergillus terreus Amphotericin B Resistance

    Article • Antimicrobial Agents and Chemotherapy, July 2017, ASM Journals

    Professor Doris Wilflingseder

  3. Promising immunotherapy against fungal diseases

    Article • Expert Opinion on Biological Therapy, May 2017, Taylor & Francis

    Professor Doris Wilflingseder

  4. Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells

    Article • PLoS Pathogens, June 2015, PLOS

    Professor Doris Wilflingseder

  5. Blocking Hsp70 Enhances the Efficiency of Amphotericin B Treatment against Resistant Aspergillus terreus Strains

    Article • Antimicrobial Agents and Chemotherapy, April 2015, ASM Journals

    Professor Doris Wilflingseder

  6. Immediate T-Helper 17 Polarization Upon Triggering CD11b/c on HIV-Exposed Dendritic Cells

    Article • The Journal of Infectious Diseases, January 2015, Oxford University Press (OUP)

    Professor Doris Wilflingseder

  7. The Viral Make-Up Makes a World of Difference

    Article • AIDS Research and Human Retroviruses, July 2014, Mary Ann Liebert Inc

    Professor Doris Wilflingseder

  8. Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats

    Article • Haematologica, June 2014, Ferrata Storti Foundation (Haematologica)

    Professor Doris Wilflingseder

  9. Shiga Toxin 2 Reduces Complement Inhibitor CD59 Expression on Human Renal Tubular Epithelial and Glomerular Endothelial Cells

    Article • Infection and Immunity, May 2013, ASM Journals

    Professor Doris Wilflingseder

  10. Role of Dendritic Cell Subsets on HIV-Specific Immunity

    Article • April 2013, IntechOpen

    Professor Doris Wilflingseder

  11. Minireview: host defence in invasive aspergillosis

    Article • Mycoses, February 2013, Wiley

    Professor Emmanuel Roilides, Professor Doris Wilflingseder

  12. Protein Kinase C Overexpression Does Not Enhance Immune-Stimulatory Surface Markers of Vaccinia-Infected Dendritic Cells and DC Cell Lines

    Article • Immunological Investigations, January 2013, Taylor & Francis

    Professor Doris Wilflingseder

  13. Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes

    Article • Journal of Allergy and Clinical Immunology, December 2012, Elsevier

    Professor Doris Wilflingseder

  14. Article • Molecular Medicine, January 2012, The Feinstein Institute for Medical Research (North Shore LIJ Research Institute)

    Professor Doris Wilflingseder

  15. Innate Immune Responses in HIV-Infection

    Article • November 2011, IntechOpen

    Professor Doris Wilflingseder

  16. Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism

    Article • Journal of Virology, March 2011, ASM Journals

    Professor Doris Wilflingseder

  17. Complement as an Endogenous Adjuvant for Dendritic Cell-Mediated Induction of Retrovirus-Specific CTLs

    Article • PLoS Pathogens, April 2010, PLOS

    Professor Doris Wilflingseder

  18. Induction of complement-mediated lysis of HIV-1 by a combination of HIV-specific and HLA allotype-specific antibodies

    Article • Immunology Letters, September 2009, Elsevier

    Professor Doris Wilflingseder

  19. Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors

    Article • Retrovirology, June 2009, Springer Science + Business Media

    Professor Doris Wilflingseder

  20. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase

    Article • Vaccine, December 2008, Elsevier

    Professor Doris Wilflingseder

  21. Complement and antibodies: A dangerous liaison in HIV infection?

    Article • Vaccine, December 2008, Elsevier

    Professor Doris Wilflingseder

  22. Complement–HIV interactions during all steps of viral pathogenesis

    Article • Vaccine, June 2008, Elsevier

    Professor Doris Wilflingseder

  23. HIV-1 induced generation of C5a attracts immature dendriticcells and promotes infection of autologous T cells

    Article • European Journal of Immunology, August 2007, Wiley

    Professor Doris Wilflingseder

  24. IgG Opsonization of HIV Impedes Provirus Formation in and Infection of Dendritic Cells and Subsequent Long-Term Transfer to T Cells

    Article • The Journal of Immunology, June 2007, The American Association of Immunologists

    Professor Doris Wilflingseder

  25. Lack of microbial DNA in tissue specimens of patients with abdominal aortic aneurysms and positive Chlamydiales serology

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 2007, Springer Science + Business Media

    Professor Doris Wilflingseder, Michael Schirmer

  26. Float on: lipid rafts in the lifecycle of HIV

    Article • Frontiers in Bioscience, January 2007, Frontiers in Bioscience

    Professor Doris Wilflingseder

  27. Factor I-Mediated Processing of Complement Fragments on HIV Immune Complexes Targets HIV to CR2-Expressing B Cells and Facilitates B Cell-Mediated Transmission of Opsonized HIV to T Cells

    Article • The Journal of Immunology, August 2006, The American Association of Immunologists

    Professor Doris Wilflingseder

  28. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model

    Article • Vaccine, March 2006, Elsevier

    Professor Doris Wilflingseder, Professor Jonathan Luke Heeney

  29. C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells

    Article • European Journal of Immunology, September 2005, Wiley

    Professor Doris Wilflingseder

  30. Complement dependent trapping of infectious HIV in human lymphoid tissues

    Article • AIDS, March 2005, Wolters Kluwer Health

    Professor Doris Wilflingseder

  31. Mechanisms promoting dendritic cell-mediated transmission of HIV

    Article • Molecular Immunology, February 2005, Elsevier

    Professor Doris Wilflingseder

  32. HIV-1-Induced Migration of Monocyte-Derived Dendritic Cells Is Associated with Differential Activation of MAPK Pathways

    Article • The Journal of Immunology, December 2004, The American Association of Immunologists

    Professor Doris Wilflingseder

  33. Mechanism(s) promoting HIV-1 infection of primary unstimulated T lymphocytes in autologous B cell/T cell co-cultures

    Article • European Journal of Immunology, August 2003, Wiley

    Professor Doris Wilflingseder

  34. Cross-Linking of CD32 Induces Maturation of Human Monocyte-Derived Dendritic Cells Via NF- B Signaling Pathway

    Article • The Journal of Immunology, April 2003, The American Association of Immunologists

    Professor Doris Wilflingseder

  35. Complement-Mediated Enhancement of HIV-1 Neutralisation by Anti-HLA Antibodies Derived from Polytransfused Patients

    Article • International Archives of Allergy and Immunology, January 2003, Karger Publishers

    Professor Doris Wilflingseder

  36. Inhibition of diamine oxidase activity by heparins

    Article • Inflammation Research, April 2000, Springer Science + Business Media

    Professor Doris Wilflingseder